454 related articles for article (PubMed ID: 21478260)
1. Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice.
Hellmann J; Tang Y; Kosuri M; Bhatnagar A; Spite M
FASEB J; 2011 Jul; 25(7):2399-407. PubMed ID: 21478260
[TBL] [Abstract][Full Text] [Related]
2. Maresin 1 improves insulin sensitivity and attenuates adipose tissue inflammation in
Martínez-Fernández L; González-Muniesa P; Laiglesia LM; Sáinz N; Prieto-Hontoria PL; Escoté X; Odriozola L; Corrales FJ; Arbones-Mainar JM; Martínez JA; Moreno-Aliaga MJ
FASEB J; 2017 May; 31(5):2135-2145. PubMed ID: 28188173
[TBL] [Abstract][Full Text] [Related]
3. The Prostaglandin E2 Receptor EP4 Regulates Obesity-Related Inflammation and Insulin Sensitivity.
Yasui M; Tamura Y; Minami M; Higuchi S; Fujikawa R; Ikedo T; Nagata M; Arai H; Murayama T; Yokode M
PLoS One; 2015; 10(8):e0136304. PubMed ID: 26308623
[TBL] [Abstract][Full Text] [Related]
4. Pancreastatin inhibitor PSTi8 protects the obesity associated skeletal muscle insulin resistance in diet induced streptozotocin-treated diabetic mice.
Gupta AP; Garg R; Singh P; Goand UK; Syed AA; Valicherla GR; Riyazuddin M; Mugale MN; Gayen JR
Eur J Pharmacol; 2020 Aug; 881():173204. PubMed ID: 32439261
[TBL] [Abstract][Full Text] [Related]
5. Resolvin D1 reduces inflammation in co-cultures of primary human macrophages and adipocytes by triggering macrophages.
Gemperle C; Tran S; Schmid M; Rimann N; Marti-Jaun J; Hartling I; Wawrzyniak P; Hersberger M
Prostaglandins Leukot Essent Fatty Acids; 2021 Nov; 174():102363. PubMed ID: 34740032
[TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone Elicits an Adiponectin-Mediated Insulin-Sensitizing Action at the Adipose Tissue-Liver Axis in Otsuka Long-Evans Tokushima Fatty Rats.
Li J; Xue YM; Zhu B; Pan YH; Zhang Y; Wang C; Li Y
J Diabetes Res; 2018; 2018():4627842. PubMed ID: 30225267
[TBL] [Abstract][Full Text] [Related]
7. Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype.
Titos E; Rius B; González-Périz A; López-Vicario C; Morán-Salvador E; Martínez-Clemente M; Arroyo V; Clària J
J Immunol; 2011 Nov; 187(10):5408-18. PubMed ID: 22013115
[TBL] [Abstract][Full Text] [Related]
8. Brd2 disruption in mice causes severe obesity without Type 2 diabetes.
Wang F; Liu H; Blanton WP; Belkina A; Lebrasseur NK; Denis GV
Biochem J; 2009 Dec; 425(1):71-83. PubMed ID: 19883376
[TBL] [Abstract][Full Text] [Related]
9. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
[TBL] [Abstract][Full Text] [Related]
10. Resolution of Inflammation by Resolvin D1 Is Essential for Peroxisome Proliferator-activated Receptor-γ-mediated Analgesia during Postincisional Pain Development in Type 2 Diabetes.
Saito T; Hasegawa-Moriyama M; Kurimoto T; Yamada T; Inada E; Kanmura Y
Anesthesiology; 2015 Dec; 123(6):1420-34. PubMed ID: 26492476
[TBL] [Abstract][Full Text] [Related]
11. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
12. Obese mice lacking inducible nitric oxide synthase are sensitized to the metabolic actions of peroxisome proliferator-activated receptor-gamma agonism.
Dallaire P; Bellmann K; Laplante M; Gélinas S; Centeno-Baez C; Penfornis P; Peyot ML; Latour MG; Lamontagne J; Trujillo ME; Scherer PE; Prentki M; Deshaies Y; Marette A
Diabetes; 2008 Aug; 57(8):1999-2011. PubMed ID: 18458147
[TBL] [Abstract][Full Text] [Related]
13. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance.
Odegaard JI; Ricardo-Gonzalez RR; Goforth MH; Morel CR; Subramanian V; Mukundan L; Red Eagle A; Vats D; Brombacher F; Ferrante AW; Chawla A
Nature; 2007 Jun; 447(7148):1116-20. PubMed ID: 17515919
[TBL] [Abstract][Full Text] [Related]
14. Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat.
Clària J; Dalli J; Yacoubian S; Gao F; Serhan CN
J Immunol; 2012 Sep; 189(5):2597-605. PubMed ID: 22844113
[TBL] [Abstract][Full Text] [Related]
15. Insulin promotes macrophage phenotype transition through PI3K/Akt and PPAR-γ signaling during diabetic wound healing.
Yu T; Gao M; Yang P; Liu D; Wang D; Song F; Zhang X; Liu Y
J Cell Physiol; 2019 Apr; 234(4):4217-4231. PubMed ID: 30132863
[TBL] [Abstract][Full Text] [Related]
16. MiR-130b promotes obesity associated adipose tissue inflammation and insulin resistance in diabetes mice through alleviating M2 macrophage polarization via repression of PPAR-γ.
Zhang M; Zhou Z; Wang J; Li S
Immunol Lett; 2016 Dec; 180():1-8. PubMed ID: 27746169
[TBL] [Abstract][Full Text] [Related]
17. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins.
González-Périz A; Horrillo R; Ferré N; Gronert K; Dong B; Morán-Salvador E; Titos E; Martínez-Clemente M; López-Parra M; Arroyo V; Clària J
FASEB J; 2009 Jun; 23(6):1946-57. PubMed ID: 19211925
[TBL] [Abstract][Full Text] [Related]
18. A novel peripheral cannabinoid 1 receptor antagonist, AJ5012, improves metabolic outcomes and suppresses adipose tissue inflammation in obese mice.
Han JH; Shin H; Park JY; Rho JG; Son DH; Kim KW; Seong JK; Yoon SH; Kim W
FASEB J; 2019 Mar; 33(3):4314-4326. PubMed ID: 30566396
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol 25-hydroxylase (CH25H) as a promoter of adipose tissue inflammation in obesity and diabetes.
Russo L; Muir L; Geletka L; Delproposto J; Baker N; Flesher C; O'Rourke R; Lumeng CN
Mol Metab; 2020 Sep; 39():100983. PubMed ID: 32229247
[TBL] [Abstract][Full Text] [Related]
20. Adipose tissue macrophages.
Zeyda M; Stulnig TM
Immunol Lett; 2007 Oct; 112(2):61-7. PubMed ID: 17719095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
